HOME ABOUT PIPELINE NEWS CAREERS CONTACT Dedicated to Innovative Drug Discovery ABOUT ETERNITY BIOSCIENCE Eternity Bioscience, Inc. (EBI) is the R&D center founded in 2009 by Hengrui Medicine as its subsidiary located at 6 Cedarbrook Drive, Cranbury New Jersey. EBI research is focusing on the discovery of innovative therapeutics for oncology, immunology, and other diseases. By coupling the biological insights determined from the target selection with structure-guided small molecule design, EBI scientists rapidly advance the small molecule leads to clinical drug candidates. Hengrui Medicine ranks as one of the top 30 pharmaceutical companies worldwide and employs more than 21,000 employees with currently close to 70-billion-dollar market value. Over 3,200 research scientists work in the ten research centers around the globe. As Hengrui's New Jersey R&D center, EBI’s mission is to deliver innovative first-in-class and/or best-in-class drug candidates for unmet medical needs. LEARN MORE People At Eternity Bioscience Inc. (EBI), we have talented researchers with excellent training at prestigious universities from around the world, with experience in research and development at top pharmaceutical companies with proven track histories in integral contributions to the delivery of clinical candidates and approved drugs. Our vision is for a culturally and scientifically diverse research team to better deliver innovative drug candidates. Every talented individual at EBI has the opportunity to develop in different roles, attain a rewarding career and make a lasting impact. Innovation At Eternity Bioscience Inc. (EBI), we maintain a focus on, and take advantage of, the current and most advanced technologies in chemistry and biology to generate disruptive ideas to invent innovative drug candidates. These innovative drug candidates will eventually be developed into novel therapeutics to benefit patients all over the world. Collaboration At Eternity Bioscience Inc. (EBI), we believe collaboration is the driving engine for innovation. We collaborate with the extensive expertise at the parent entity Hengrui Medicine Group including all family members and research groups globally. We collaborate extensively with big and small pharmaceutical and biotech companies, and contract research organizations (CROs). We continuously seek collaboration opportunities. Proudly powered by Weebly